90Y-Yttrium Citrate

90Y-Yttrium Citrate

90Y-Yttrium Citrate is a radiopharmaceutical compound used in nuclear medicine for therapeutic purposes. It consists of the radioisotope Yttrium-90 (90Y) bound to citrate, a chelating agent that helps in the delivery of the radioactive isotope to the target tissues. In the context of therapeutic radiosynovectomy for large joints such as… Continue Reading…

90Y-TheraSphere

90Y-TheraSphere

90Y-TheraSphere is a type of radioembolization therapy used in the treatment of liver cancer. It involves the use of small beads called TheraSphere that are loaded with the radioactive isotope Yttrium-90 (90Y). These beads are delivered directly into the blood vessels that supply the tumor in the liver, where they… Continue Reading…

90Y-SIR-Spheres

90Y-SIR-Spheres

90Y-SIR-Spheres is a type of radioembolization therapy used in the treatment of liver cancer. It involves the use of tiny resin or glass beads (SIR-Spheres) that are filled with the radioactive isotope yttrium-90 (90Y). These beads are injected into the blood vessels that supply the liver tumor, where they become… Continue Reading…

90Y-IsoPet

90Y-IsoPet

90Y-IsoPet is a novel radiopharmaceutical used in the field of nuclear medicine for targeted radiation therapy. It consists of the radioisotope yttrium-90 (90Y) attached to a specific targeting molecule, which allows for the selective delivery of radiation to cancer cells. The targeting molecule used in 90Y-IsoPet is designed to bind… Continue Reading…

90Y-Ibritumomab Tiuxetan (Zevalin®)

90Y-Ibritumomab Tiuxetan (Zevalin®)

90Y-Ibritumomab Tiuxetan (Zevalin®) is a radiopharmaceutical used in the treatment of certain types of non-Hodgkin’s lymphoma. It consists of two main components: the monoclonal antibody ibritumomab and the radioactive isotope yttrium-90 (90Y). Ibritumomab is a monoclonal antibody that specifically targets a protein called CD20, which is found on the surface… Continue Reading…

89Sr-Strontium Chloride

89Sr-Strontium Chloride

Strontium chloride is a chemical compound that consists of strontium cations (Sr2+) and chloride anions (Cl–). When combined with the radioactive isotope 89Sr, it forms 89Sr-Strontium Chloride, which is used as a radiopharmaceutical for the treatment of bone cancer. Strontium-89 (89Sr) is a radioactive isotope of strontium that is commonly… Continue Reading…

32P-Sodium Phosphate

32P-Sodium Phosphate

32P-Sodium Phosphate is a radioactive form of phosphorus that is commonly used in molecular biology and biochemistry research. The isotope 32P is produced by bombarding a stable isotope of sulfur with neutrons in a nuclear reactor. The resulting radioactive phosphorus is then typically incorporated into molecules such as nucleotides, proteins,… Continue Reading…

32P-OncoSil

32P-OncoSil

32P-OncoSil is a brachytherapy device that combines the benefits of radioactive phosphorus-32 (32P) with biodegradable silica particles for the treatment of solid tumors. Brachytherapy is a form of radiation therapy where radioactive sources are placed directly into or next to the tumor, allowing for precise delivery of radiation to the… Continue Reading…

32P-Chromic Phosphate

32P-Chromic Phosphate

32P-Chromic Phosphate is a radiopharmaceutical compound that has been used in the treatment of various medical conditions, particularly in the field of nuclear medicine. This radiopharmaceutical consists of the radioisotope phosphorus-32 (32P) bound to chromic phosphate, a compound that facilitates the delivery of the radioactive phosphorus to target tissues within… Continue Reading…

14C-Urea

14C-Urea

Description 14C-Urea (or Pytest; 14C-Urea breath test) is a qualitative and non-invasive method for the diagnosis of Helicobacter pylori. It consists of 14C-labeled urea absorbed on sugar pellets. This not an imaging technology, but a simple biological radioactive diagnostic tool. Clinical applications 14C-Pytest is a diagnostic procedure used to identify… Continue Reading…

Yttrium-90 (90Y)

Yttrium-90 (90Y)

Yttrium-90 is a radioactive isotope of the element yttrium with a half-life of approximately 64 hours. It is commonly used in targeted radiation therapy, known as radioembolization, for the treatment of certain types of liver cancer, such as hepatocellular carcinoma and metastatic liver tumors. In radioembolization, tiny resin or glass… Continue Reading…

Samarium-153 (153Sm)

Samarium-153 (153Sm)

Properties: Samarium-153 (153Sm) is a beta emitter with a half-life of 46.3 hours. It emits electrons (β–) at 705 keV (49.6%), 635 keV (32.2%) and 808 keV (17.5%). It emits also a gamma at 103 keV (30%). The mean path length is 1.2 mm. Tenth value layer (TVL) is 12… Continue Reading…